• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚针具和注射器项目对注射吸毒者中艾滋病毒和丙型肝炎病毒传播的影响:基于模型的分析

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.

作者信息

Kwon Jisoo A, Iversen Jenny, Maher Lisa, Law Matthew G, Wilson David P

机构信息

National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, New South Wales, Australia.

出版信息

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):462-9. doi: 10.1097/QAI.0b013e3181a2539a.

DOI:10.1097/QAI.0b013e3181a2539a
PMID:19387355
Abstract

OBJECTIVES

We aim to estimate how changes in sterile syringe distribution through needle-syringe programs (NSPs) may affect HIV and hepatitis C virus (HCV) incidence among injecting drug users (IDUs) in Australia.

METHODS

We develop a novel mathematical model of HIV and HCV transmission among IDUs who share syringes. It is calibrated using biological and Australian epidemiological and behavioral data. Assuming NSP syringe distribution affects the number of times each syringe is used before disposal, we use the model to estimate the relationship between incidence and syringe distribution.

RESULTS

HIV is effectively controlled through NSP distribution of sterile syringes {with the effective reproduction ratio below 1 [0.66 median, interquartile range (0.63-0.70)] under current syringe distribution}. In contrast, HCV incidence is expected to remain high and its control is not feasible in the foreseeable future. The proportion of injections that are shared and the number of times each syringe is used before disposal are the driving factors of HCV incidence. The frequency in which each syringe is used can potentially be influenced by changes in syringe distribution. We estimate that if syringe distribution or coverage doubled, then annual incidence is likely to reduce by 50%. However, if it was decreased to one third of the current level, then approximately 3 times the incidence could be expected.

CONCLUSIONS

This research highlights the large benefits of NSPs, puts forward a quantitative relationship between incidence and syringe distribution, and indicates that increased coverage could result in significant reductions in viral transmissions among IDUs.

摘要

目的

我们旨在评估通过针头-注射器项目(NSPs)进行的无菌注射器分发变化如何影响澳大利亚注射吸毒者(IDUs)中的艾滋病毒和丙型肝炎病毒(HCV)发病率。

方法

我们建立了一个关于共用注射器的注射吸毒者中艾滋病毒和丙型肝炎病毒传播的新型数学模型。该模型使用生物学以及澳大利亚的流行病学和行为学数据进行校准。假设NSP注射器分发会影响每个注射器在丢弃前的使用次数,我们使用该模型来估计发病率与注射器分发之间的关系。

结果

通过NSP分发无菌注射器可有效控制艾滋病毒{在当前注射器分发情况下,有效繁殖率低于1[中位数为0.66,四分位间距(0.63 - 0.70)]}。相比之下,预计丙型肝炎病毒发病率仍将居高不下,并且在可预见的未来其控制是不可行的。共用注射的比例以及每个注射器在丢弃前的使用次数是丙型肝炎病毒发病率的驱动因素。每个注射器的使用频率可能会受到注射器分发变化的影响。我们估计,如果注射器分发或覆盖率翻倍,那么年发病率可能会降低50%。然而,如果降至当前水平的三分之一,那么发病率可能会增加约3倍。

结论

本研究突出了NSPs的巨大益处,提出了发病率与注射器分发之间的定量关系,并表明增加覆盖率可显著减少注射吸毒者中的病毒传播。

相似文献

1
The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.澳大利亚针具和注射器项目对注射吸毒者中艾滋病毒和丙型肝炎病毒传播的影响:基于模型的分析
J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):462-9. doi: 10.1097/QAI.0b013e3181a2539a.
2
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.在一个注射器交换和药房注射器分发均属非法的城市,注射毒品感染艾滋病毒、乙肝病毒和丙肝病毒的风险更高。
J Urban Health. 2008 May;85(3):309-22. doi: 10.1007/s11524-008-9271-1. Epub 2008 Mar 14.
3
Estimating the cost-effectiveness of needle-syringe programs in Australia.评估澳大利亚针具交换项目的成本效益。
AIDS. 2012 Nov 13;26(17):2201-10. doi: 10.1097/QAD.0b013e3283578b5d.
4
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.有证据表明,提供无菌注射设备可有效预防注射吸毒者中丙型肝炎和人类免疫缺陷病毒的传播:综述的综述。
Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2.
5
Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.冲突环境下丙型肝炎和艾滋病毒的发病率以及减少伤害项目的使用情况:阿富汗喀布尔注射吸毒者的一项观察性队列研究
Harm Reduct J. 2015 Oct 16;12:22. doi: 10.1186/s12954-015-0056-z.
6
Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.为注射吸毒者提供最佳的针具和注射器方案:系统评价。
Int J Drug Policy. 2010 Sep;21(5):335-42. doi: 10.1016/j.drugpo.2010.02.001. Epub 2010 Feb 26.
7
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.针具和注射器提供以及阿片类物质替代疗法对注射吸毒者丙型肝炎病毒感染发生率的影响:英国证据汇总。
Addiction. 2011 Nov;106(11):1978-88. doi: 10.1111/j.1360-0443.2011.03515.x. Epub 2011 Aug 24.
8
Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.澳大利亚针具交换项目参与者的个人用注射器覆盖率。
Drug Alcohol Depend. 2012 May 1;122(3):195-200. doi: 10.1016/j.drugalcdep.2011.09.030. Epub 2011 Nov 8.
9
Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.澳大利亚注射吸毒者参与针具交换项目后 HCV 发病率降低:一项关联研究。
Am J Public Health. 2013 Aug;103(8):1436-44. doi: 10.2105/AJPH.2012.301206. Epub 2013 Jun 13.
10
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.高覆盖率的针具/注射器方案在中低收入国家的注射吸毒人群中的应用:一项系统评价。
BMC Public Health. 2013 Jan 19;13:53. doi: 10.1186/1471-2458-13-53.

引用本文的文献

1
How competing needs after incarceration lead to adverse health outcomes among people who use criminalized drugs.监禁后的各种相互竞争的需求如何导致使用被定罪药物者出现不良健康结果。
BMC Glob Public Health. 2025 May 1;3(1):36. doi: 10.1186/s44263-025-00152-y.
2
Hepatitis C virus transmission among people who inject drugs in the Middle East and North Africa: mathematical modeling analyses of incidence and intervention impact.中东和北非地区注射吸毒人群中的丙型肝炎病毒传播:发病率及干预影响的数学建模分析
EClinicalMedicine. 2025 Jan 15;80:103040. doi: 10.1016/j.eclinm.2024.103040. eCollection 2025 Feb.
3
Cost-benefit analysis of Canada's Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections.
加拿大监狱针头交换项目预防丙型肝炎及注射相关感染的成本效益分析。
CMAJ. 2024 Dec 15;196(43):E1401-E1412. doi: 10.1503/cmaj.240648.
4
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.消除 HCV 感染:近年流行病学发现、障碍及未来策略。
Viruses. 2024 Nov 19;16(11):1792. doi: 10.3390/v16111792.
5
Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study.踏进私人空间:将丙型肝炎护理链扩展到自动针/注射器分发机,一项混合方法研究。
Harm Reduct J. 2022 May 28;19(1):56. doi: 10.1186/s12954-022-00640-6.
6
Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence data.利用序列数据定量评估异质人群中急性丙型肝炎病毒感染的传播动力学。
PLoS Pathog. 2021 Sep 14;17(9):e1009916. doi: 10.1371/journal.ppat.1009916. eCollection 2021 Sep.
7
Innovations in Hepatitis C Screening and Treatment.丙型肝炎的筛查和治疗创新。
Hepatol Commun. 2020 Dec 7;5(3):371-386. doi: 10.1002/hep4.1646. eCollection 2021 Mar.
8
Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.丙型肝炎病毒(HCV)预防的数学建模:文献综述及消除策略的见解。
J Theor Biol. 2019 Nov 21;481:194-201. doi: 10.1016/j.jtbi.2018.11.013. Epub 2018 Nov 16.
9
Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.模拟全国范围内扩大干预措施对苏格兰注射毒品人群中丙型肝炎病毒传播的影响。
Addiction. 2018 Nov;113(11):2118-2131. doi: 10.1111/add.14267. Epub 2018 Jul 10.
10
HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.中东和北非地区注射吸毒人群中的艾滋病毒感染率:数学建模分析。
J Int AIDS Soc. 2018 Mar;21(3):e25102. doi: 10.1002/jia2.25102.